农药涨价品种及龙头企业分析 20260226 摘要 烯草酮和氯虫苯甲酰胺因供给侧冲击在 2025 年价格显著上涨，而草甘 膦作为代表性除草剂，价格年内波动后回落，后续价格受海外政策和国 内供给约束影响，预计有望回升至 26,000 元左右。 2025 年农药行业供需错配突出，吡虫啉等品种因扩产导致结构性过剩， 丙硫菌唑与戊唑醇等杀菌剂设计产能持续超过市场需求，整体价格承压。 2026 年初连续安全事故促使监管层加强对农化市场治理和产能控制的 决心，预计 2026 年明确方向与目标，2027 年进入实质执行阶段，销 售收入 10 亿元以下的企业面临更大压力。 草铵膦价格已大幅下降，主要由于供给端扩产，即使上涨，空间也有限。 烯草酮在 2025 年已大幅上涨，阿维菌素预计仍可缓慢上涨，甲维盐受 专利约束影响，2026 年价格或将继续上涨。 高效氯氟氰菊酯与氯氟氰菊酯价格处于近十年低位，价格能否上行取决 于后续产能控制能否落地。麦草畏短期判断价格有望上涨 1 万以上至 9 万，长期看可到 10 万。 Q&A 2025 年农药行业整体供需与价格表现如何，哪些品种出现了显著涨价，背后 的驱动因素是什么？ 2025 年中 ...

氯虫苯甲酰胺大幅涨价，行业自律促进价格持续上调【中泰建材&化工|孙颖团队】 事件：2月26日氯虫苯甲酰胺价格上调2.35万元至21万元/吨，日环比上调12.6%。 点评：应急管理部组织在全国范围内开展危化品等非法生产窝点清查整治，特别针对2月7日事故涉及的2-硝基-3- 甲基苯甲酸（氯虫苯甲酰胺关键中间体k胺的前体）。 #氯虫苯甲酰胺企业外采需求旺盛，k胺供应紧张将推动价格上涨。 2025年友道化学发生爆炸后，其5000吨k胺产能至今处于停车，下游企业为保障生产导致非法k胺产能泛滥。 当前加强对k胺中间体的管控将进一步加剧供应紧张局面，而k胺合规产能稀缺，目前仅有红太阳等极少数龙头企 业具备氯虫苯甲酰胺生产所需的k胺自配产能，绝大多数企业均需通过外采满足需求。 #行业自律将持续推动价格上涨。 2月10日，中国农药工业协会出台文件，经测算氯虫苯甲酰胺企业平均生产成本为23.3万元/吨，要求相关企业不得 低于平均成本销售，并要求从合规渠道采购原材料。 由于k胺生产含高危硝化工艺，合规审批困难，出现山西佳鹏等一批非 氯虫苯甲酰胺大幅涨价，行业自律促进价格持续上调【中泰建材&化工|孙颖团队】 事件：2月26日氯虫苯甲 ...

Core Viewpoint - Lier Chemical (SZ002258) experienced a limit-up on January 19, 2026, with a price of 16.38 yuan, marking a 10.01% increase, and a total market capitalization of 13.111 billion yuan [1] Group 1: Company Performance - Lier Chemical reported exceptional performance in 2025, with a net profit growth of 189.07% year-on-year in the third quarter, and an annual net profit forecast growth of 113.62% to 132.19% [2] - The company's operating cash flow increased by 322.30% year-on-year, indicating significant improvement in operational quality and profitability [2] Group 2: Production and Market Demand - The company launched a 20,000 tons/year enzymatic glyphosate project in Hunan, solidifying its position as the largest raw material producer in China [2] - With glyphosate prices remaining low, the cost-effectiveness of products has significantly improved, leading to sustained growth in market demand [2] - Lier Chemical is expected to benefit directly from the increasing demand for glyphosate alternatives, as it continues to expand its market share and receive good orders [2] Group 3: Industry Trends - The recent cessation of glyphosate production and sales by Bayer, a major player in the seed industry, has increased market demand for glyphosate alternatives, positively impacting related stocks [2] - On January 19, there was a noticeable inflow of funds into the pesticide and fertilizer sector, with multiple stocks, including Lier Chemical, hitting their limit-up, indicating a correlated market response [2] Group 4: Technical Analysis - The MACD indicator for Lier Chemical formed a golden cross in early January, and the stock price broke through short-term resistance levels, suggesting a bullish trend [2] - Data from Dongfang Caifu shows a continuous increase in net buying from large orders between January 18 and 19, reflecting strong confidence from major investors in the company [2]

Investment Rating - The industry investment rating is "Outperform the Market - A" and the rating is maintained [5]. Core Insights - The new pesticide export tax rebate policy is expected to drive a "reverse involution" in the industry, potentially boosting prices and accelerating long-term transformation [1]. - The cancellation of the export tax rebate for certain pesticide products will increase export costs, leading companies to have a strong willingness to maintain prices [2]. - The policy aims to accelerate the elimination of low-quality production capacity and guide the industry towards a high-quality development direction by shifting the export structure from raw materials to formulations [3]. Summary by Sections Short-term Outlook - The upcoming spring farming season and the cancellation of the export tax rebate will provide dual support for pesticide prices, as companies may increase prices to maintain profitability [2]. Long-term Outlook - The domestic pesticide industry is experiencing high growth in investment and new projects, with an expected increase in production capacity of approximately 1.4 million tons per year from 2021 to 2024 [3]. - The policy is expected to improve capacity utilization rates, which are currently low at 66% compared to the national average for large-scale industries [3]. Industry Performance - The industry has shown strong relative performance with a 1-month return of 8.2%, a 3-month return of 10.1%, and a 12-month return of 26.1% [8].

Group 1: Industry Overview - The pesticide industry remains highly competitive, with major pesticide product prices stabilizing at low levels, but global inventory levels are returning to normal, leading to signs of demand recovery and price increases for some products [2] - The market for glyphosate is expected to grow due to increasing product registrations and market promotions, with the company being the largest domestic producer [2][3] Group 2: Product Development and Market Strategy - The company has a 20,000 tons/year enzymatic glyphosate project in Hunan that has commenced production, with normal operational conditions [3] - The company plans to enhance its market share by improving product cost-effectiveness and expanding market demand through new product development [3] Group 3: Future Outlook and Strategic Initiatives - The company is optimistic about the market prospects for chlorantraniliprole and is actively optimizing production processes while constructing production facilities [3] - Future development plans include technological upgrades to existing products, cost reduction, and increasing new profit sources through market expansion and new product launches [3] Group 4: Shareholder Changes - The controlling shareholder, Jiuyuan Group, has announced plans to transfer part of its shares through a public solicitation process, pending approval from relevant authorities, which introduces uncertainty regarding the timing and feasibility of the transfer [3]

Investment Rating - The report rates the pesticide industry as "Outperform the Market" [1][5] Core Insights - The Chinese pesticide industry is expected to transition from "Me too" to "Me better" in terms of innovation and product development [1][2] - The global pesticide market is projected to reach approximately $77.2 billion in 2024, with a compound annual growth rate (CAGR) of 2.35% over the next decade [1][13] - Non-patented pesticides dominate the market, accounting for 93% of the global pesticide market share, while patented pesticides hold only 7% [1][14] Summary by Sections Pesticide Market Overview - The global pesticide market is expected to be approximately $77.2 billion in 2024, with agricultural pesticides making up $70.1 billion and non-agricultural pesticides $7.1 billion [1][13] - The market share of herbicides, fungicides, and insecticides in the global crop protection market is 47.20%, 24.96%, and 24.97% respectively [1][13] New Pesticide Development Challenges - The difficulty of developing new pesticides has increased significantly, with the average cost of bringing a new pesticide to market now around $300 million and taking approximately 12 years [1][45] - The number of new active ingredients introduced globally every decade has decreased, indicating a growing challenge in pesticide innovation [1][43] China's Pesticide Industry Strength - China has become the world's largest pesticide producer and exporter, with nearly 70% of global active ingredient production and 90% of its production being exported [2][2] - From 2020 to 2024, China accounted for 51.61% of the new pesticides developed globally, establishing itself as a key player in pesticide innovation [2][2] Investment Recommendations - The report recommends focusing on domestic pesticide companies that are actively advancing new pesticide development, including: - Yangnong Chemical: Holds 12 new pesticides with complete independent intellectual property rights [3][4] - Lier Chemical: Promoting patented plant immune activator [3][4] - Limin Chemical: Collaborating with BASF to apply AI in pesticide development [3][4] - Jiangshan Chemical: Preparing for the industrialization of a new herbicide [3][4] Key Company Profit Forecasts - Yangnong Chemical: Rated "Outperform the Market" with an estimated EPS of 3.33 in 2025 and a PE ratio of 19.7 [4] - Lier Chemical: Rated "Outperform the Market" with an estimated EPS of 0.62 in 2025 and a PE ratio of 21.0 [4] - Limin Chemical: Rated "Outperform the Market" with an estimated EPS of 1.26 in 2025 and a PE ratio of 12.7 [4] - Jiangshan Chemical: Rated "Outperform the Market" with an estimated EPS of 1.41 in 2025 and a PE ratio of 16.1 [4]

Group 1: Industry Overview - The pesticide industry remains highly competitive, with major pesticide product prices stabilizing at low levels, but global inventory levels are returning to normal, leading to a slight recovery in demand and prices [2] - The market for glyphosate is expected to grow due to increasing product registrations, market promotions, and production technology improvements [2] Group 2: Company Insights - The company is the largest producer of glyphosate in China, with increasing market share and sales year-on-year [2] - The company is actively pursuing global market registrations for glyphosate, with approvals being obtained progressively [2] Group 3: Product Development and Future Plans - The company is optimistic about the market prospects for chlorantraniliprole, with significant efforts in market layout and production process optimization [3] - Future development plans include continuous technological upgrades, cost reduction, and enhancing product competitiveness, alongside expanding market demand through new product development [3] Group 4: Shareholder Changes - The controlling shareholder, Jiuyuan Group, has announced plans to transfer part of its shares through a public solicitation process, pending approval from relevant authorities [3] - The timeline and certainty of the transfer process remain unclear, and the company will ensure compliance with information disclosure regulations [3]

Core Viewpoint - The company emphasizes its long-term value creation through various strategic initiatives and core competencies [2] Group 1: Core Products and Market Position - The company possesses global influence and technical barriers with core products such as pyridine, paraquat, glyphosate, and chlorantraniliprole [2] Group 2: Technological Advancements and Efficiency - The company is continuously advancing technological upgrades and capacity enhancements to improve industry chain efficiency and cost advantages [2] Group 3: New Energy and Sustainability Initiatives - The company is actively investing in biomanufacturing and biomass new energy sectors, aligning with the national "dual carbon" strategy [2] Group 4: Governance and Compliance - The company is committed to improving its governance structure, enhancing compliance operations, and internal control supervision to lay a foundation for sustainable development [2] Group 5: Focus on Core Business - The company will continue to focus on its main business, enhance operational quality, and strive to create long-term stable returns for shareholders [2]

Core Viewpoint - The company is actively working on technological upgrades for its core products and is making steady progress on new projects despite delays in their launch [1] Group 1 - The company has been focusing on technological upgrades for its main products, including Paraquat, Glyphosate, and Chlorantraniliprole [1] - Important intermediates such as Pyridine, 2,3-Dichloropyridine, 2,2'-Bipyridine, and Pyrazole acid are also undergoing successful technological improvements [1] - The new projects are progressing steadily, indicating a commitment to future growth and development [1]

Core Viewpoint - The company expresses confidence in its overall performance for 2025, citing strong operational results as a foundation for its value and stock performance [1] Group 1: Product Portfolio and Market Position - The company offers a diverse range of products including herbicides, insecticides, and intermediates, with key products like pyridine, paraquat, diquat dichloride, and chlorantraniliprole holding significant market influence [1] - It is anticipated that the price of paraquat will stabilize and recover in 2025, contributing to profit growth as the agricultural pesticide industry recovers [1] Group 2: Cost Management and Efficiency Improvements - The company is actively pursuing technological upgrades and efficiency improvements in its pyridine and chlorantraniliprole production chains, aiming to reduce costs and enhance productivity through process optimization and supply chain integration [1] Group 3: New Projects and Growth Drivers - New projects, such as L-phosphinothricin, are progressing as planned and are expected to provide new growth momentum for the company [1] Group 4: Market Expansion and Export Recovery - The company is making strides in product registration and partnership agreements in both domestic and international markets, leading to a recovery in export business [1] - The company aims to enhance profitability and development quality through solid operations, continuous innovation, and meticulous management, ultimately creating long-term stable returns for investors [1]